Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-104705
Filing Date
2025-08-07
Accepted
2025-08-07 11:36:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9084
  Complete submission text file 0000950170-25-104705.txt   10824
Mailing Address 11 HUGHES IRVINE CA 92618
Business Address 11 HUGHES IRVINE CA 92618 949-427-7785
Beta Bionics, Inc. (Subject) CIK: 0001674632 (see all company filings)

EIN.: 475386878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)